Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Thermo Fisher Scientific Inc (TMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 77,008,408
  • Shares Outstanding, K 400,210
  • Annual Sales, $ 18,274 M
  • Annual Income, $ 2,022 M
  • 36-Month Beta 1.05
  • Price/Sales 4.24
  • Price/Cash Flow 15.14
  • Price/Book 3.38

Price Performance

See More
Period Period Low Period High Performance
1-Month
185.98 +2.85%
on 09/25/17
194.12 -1.46%
on 10/13/17
+0.65 (+0.34%)
since 09/15/17
3-Month
170.07 +12.47%
on 08/11/17
194.30 -1.55%
on 09/12/17
+10.33 (+5.71%)
since 07/14/17
52-Week
139.07 +37.54%
on 12/01/16
194.30 -1.55%
on 09/12/17
+39.57 (+26.08%)
since 10/14/16

Most Recent Stories

More News
Here's Why You Should Buy Thermo Fisher Scientific (TMO) Now

Based on a wide range of fundamental factors, Thermo Fisher (TMO) is a great pick for now.

ABT : 54.63 (-0.04%)
TMO : 191.28 (-0.59%)
IART : 49.15 (-0.04%)
IDXX : 158.55 (-0.66%)
Here's Why Investors Should Buy Integra LifeSciences Now

The market is upbeat about Integra LifeSciences' (IART) latest developments that include product launches and strategic buyouts.

ABT : 54.63 (-0.04%)
TMO : 191.28 (-0.59%)
IART : 49.15 (-0.04%)
IDXX : 158.55 (-0.66%)
TransEnterix Senhance Surgical Robotic System Wins FDA Nod

TransEnterix (TRXC) works on expanding in robotic surgery consistently.

ABT : 54.63 (-0.04%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
TRXC : 2.81 (+92.47%)
Henry Schein Gains on Strategic Buyouts, Cost Concern a Woe

Henry Schein (HSIC) continues to grow on dental and animal health business, thanks to merger and acquisition activity. However, rising costs continue to be a burden on the company's bottom line.

HSIC : 81.91 (+1.21%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
QGEN : 34.52 (-0.38%)
NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval

NuVasive's (NUVA) latest receipt of expanded FDA 510(k) approval for PRECICE is likely to fortify its hold in the limb reconstruction and trauma market.

NUVA : 52.18 (+2.68%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
QGEN : 34.52 (-0.38%)
Abbott Banks on FDA Approvals and Buyouts, Competition Rife

The market is upbeat about Abbott's (ABT) latest initiatives.

ABT : 54.63 (-0.04%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
QGEN : 34.52 (-0.38%)
Bruker (BRKR) at a 52-Week High: What's Driving the Stock?

The new 52-week high of Bruker (BRKR) came on the back of several new initiatives, the most recent one being the introduction of the new CE-IVD marked Fungiplex Candida fast diagnostic assay.

TMO : 191.28 (-0.59%)
BRKR : 30.94 (+0.16%)
IDXX : 158.55 (-0.66%)
QGEN : 34.52 (-0.38%)
MedTech Players Eyeing Emerging Market Growth Opportunities

The gloomy eco-political scenario in the United States and Europe points toward the fact that emerging geographies are playing a crucial role in the growth of the MedTech space globally.

ABT : 54.63 (-0.04%)
BSX : 29.16 (-0.95%)
JNJ : 136.12 (-0.23%)
TMO : 191.28 (-0.59%)
MDT : 77.73 (-0.44%)
LabCorp (LH) Strong on Strategic Planning, Competition Rife

LabCorp (LH) grows on strong diagnostics business amid softness in the Covance drug development business.

TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
QGEN : 34.52 (-0.38%)
LH : 149.67 (+0.05%)
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

DENTSPLY SIRONA's (XRAY) renewed distribution deal will aid the company to gain market traction. However, forex woes remain a concern.

ABT : 54.63 (-0.04%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
XRAY : 59.19 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab...

See More

Support & Resistance

2nd Resistance Point 194.44
1st Resistance Point 192.86
Last Price 191.28
1st Support Level 190.23
2nd Support Level 189.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart